SCHEMBL29915928

SCHEMBL29915928

Cc1ccc(-c2nc(C(C)(C)C)ccc2C(N)=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
PARP1 P09874 1/20 0.42
NNMT P40261 1/20 0.41
IKBKB O14920 2/20 0.40
ALDH1A1 P00352 2/20 0.39
CDC7 O00311 1/20 0.39
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
AHR P35869 1/20 0.38
RAB9A P51151 1/20 0.38
GRM2 Q14416 1/20 0.38
PDGFRB P09619 1/20 0.37
KDR P35968 1/20 0.37
HPGD P15428 2/20 0.37
BTK Q06187 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17647519 0.86 SMN1; SMN2 (0.55) SMN1; SMN2IKBKBALDH1A1MAPTRAB9A
SCHEMBL29915627 0.76 EGFR (0.52) SMN1; SMN2ALDH1A1KDR
SCHEMBL17647887 0.76 EGFR (0.52) SMN1; SMN2ALDH1A1KDR
SCHEMBL17647991 0.74 PTGS2 (0.55) ALDH1A1KDRHPGDKDM4E
SCHEMBL29915876 0.74 EGFR (0.53) KDR
SCHEMBL17649302 0.74 EGFR (0.53) KDR
SCHEMBL17268296 0.73 NNMT (0.41) PARP1NNMTALDH1A1KDM4EGAA
SCHEMBL28943763 0.73 NNMT (0.41) SMN1; SMN2PARP1NNMTALDH1A1MAPT
SCHEMBL17646635 0.72 EGFR (0.46) KDRKDM4E
SCHEMBL22383334 0.72 PTGS2 (0.47) CA12CA9CA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3798214-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2022-09-14 EP claimed